Metformin Use Prior to Admission for Pneumonia Decreases Mortality Risk
Researchers evaluated whether metformin use prior to hospitalization for community-acquired pneumonia decreases the risk of mortality in older patients with diabetes.
Researchers evaluated whether metformin use prior to hospitalization for community-acquired pneumonia decreases the risk of mortality in older patients with diabetes.
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
How does lung ultrasound compare with thoracic computed tomography in determining the severity of COVID-19 pneumonia?
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
What kinds of pulmonary sequelae do patients experience a year after hospitalization with COVID-19 pneumonia — and does the level of ventilatory support matter?
Can nonsevere childhood community-acquired pneumonia be effectively treated by a short course of antibiotics?
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
How does methylprednisolone dose and duration affect rates of VTE and mortality among patients with COVID-19 pneumonia?
The randomized, double-blind, placebo-controlled study included a total of 380 patients aged 6 to 71 months with nonsevere CAP.